Allergy or an infection – bilastine treatment Review article
Article Sidebar
Published:
Sep 30, 2015
Keywords:
upper respiratory tract infection, allergic rhinitis, bilastine
Main Article Content
Abstract
Upper respiratory tract infection is a common problem both in children and in adults. Differential diagnosis might be difficult. For almost 70 years viral infections are treated with many drugs, including oral antihistamines. Albeit, we know that we use them off-label. Several of them including the newest in market – bilastine – revealed some anti-inflammatory properties. Can we safely use it in case of diagnosis is difficult to be established?
Article Details
How to Cite
Pawliczak , R. (2015). Allergy or an infection – bilastine treatment. Medycyna Faktow (J EBM), 8(3(28), 56-59. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2297
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Rantala A., Jaakkola J.J., Jaakkola M.S.: Respiratory infections in adults with atopic disease and IgE antibodies to common aeroallergens. PLoS One; 8(7): e68582.
2. Brewster J.M.: Benadryl as a therapeutic agent in the treatment of the common cold. U.S. Nav. Med. Bull. 1947; 47(5): 810.
3. West S., Brandon B., Stolley P., Rumrill R.: A review of antihistamines and the common cold. Pediatrics 1975; 56(1): 100-107.
4. Arroll B.: Non-antibiotic treatments for upper-respiratory tract infections (common cold). Respir. Med. 2005; 99(12): 1477-1484.
5. Arroll B.: Common cold. BMJ Clin. Evid. 2008: 06: 1510-1520.
6. De Sutter A.I., van Driel M.L., Kumar A.A. et al.: Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst. Rev.; 2: CD004976.
7. Krause K., Spohr A., Zuberbier T. et al.: Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013; 68(7): 921-928.
8. Bousquet J., Ansotegui I., Canonica G.W. et al.: Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review. Curr. Med. Res. Opin. 2012; 28(1): 131-139.
9. Garcia-Gea C., Martinez J., Ballester M.R. et al.: Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials. Hum. Psychopharmacol. 2014; 29(2): 120-132.
10. Graff C., Struijk J.J., Kanters J.K. et al.: Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebocontrolled, thorough QTc study. Clin. Drug. Investig. 2015; 32(5): 339-351.
11. Horak F., Zieglmayer P., Zieglmayer R., Lemell P.: The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. Inflamm. Res.; 59(5): 391-398.
12. Church M.K.: Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria. Expert Opin. Drug Saf. 2011; 10(5): 779-793.
13. ChPL Clatra 13.01.2012.
14. Krause K., Spohr A., Zuberbier T. et al.: Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013; 68(7): 921-928.
2. Brewster J.M.: Benadryl as a therapeutic agent in the treatment of the common cold. U.S. Nav. Med. Bull. 1947; 47(5): 810.
3. West S., Brandon B., Stolley P., Rumrill R.: A review of antihistamines and the common cold. Pediatrics 1975; 56(1): 100-107.
4. Arroll B.: Non-antibiotic treatments for upper-respiratory tract infections (common cold). Respir. Med. 2005; 99(12): 1477-1484.
5. Arroll B.: Common cold. BMJ Clin. Evid. 2008: 06: 1510-1520.
6. De Sutter A.I., van Driel M.L., Kumar A.A. et al.: Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst. Rev.; 2: CD004976.
7. Krause K., Spohr A., Zuberbier T. et al.: Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013; 68(7): 921-928.
8. Bousquet J., Ansotegui I., Canonica G.W. et al.: Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review. Curr. Med. Res. Opin. 2012; 28(1): 131-139.
9. Garcia-Gea C., Martinez J., Ballester M.R. et al.: Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials. Hum. Psychopharmacol. 2014; 29(2): 120-132.
10. Graff C., Struijk J.J., Kanters J.K. et al.: Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebocontrolled, thorough QTc study. Clin. Drug. Investig. 2015; 32(5): 339-351.
11. Horak F., Zieglmayer P., Zieglmayer R., Lemell P.: The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. Inflamm. Res.; 59(5): 391-398.
12. Church M.K.: Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria. Expert Opin. Drug Saf. 2011; 10(5): 779-793.
13. ChPL Clatra 13.01.2012.
14. Krause K., Spohr A., Zuberbier T. et al.: Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013; 68(7): 921-928.